Pfizer - 52 Year Stock Price History | PFE

Historical daily share price chart and data for Pfizer since 1972 adjusted for splits and dividends. The latest closing stock price for Pfizer as of July 26, 2024 is 30.77.
  • The all-time high Pfizer stock closing price was 54.30 on December 16, 2021.
  • The Pfizer 52-week high stock price is 37.19, which is 20.9% above the current share price.
  • The Pfizer 52-week low stock price is 25.20, which is 18.1% below the current share price.
  • The average Pfizer stock price for the last 52 weeks is 29.68.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Pfizer Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 27.1583 28.4638 30.7700 24.5539 30.7700 11.63%
2023 34.4749 46.9146 46.9146 25.0171 27.5638 -41.22%
2022 44.9151 50.2258 50.2613 37.8854 46.8963 -10.42%
2021 36.8102 31.3985 54.3042 28.8773 52.3537 66.74%
2020 29.2502 30.3992 36.3032 22.3544 31.3985 3.18%
2019 30.4765 32.3927 33.8330 26.3366 30.4303 -6.92%
2018 28.8902 26.3507 34.6246 24.5432 32.6922 24.82%
2017 24.2195 22.9637 26.9002 21.6764 26.1916 15.88%
2016 22.4541 21.4151 25.4892 19.3365 22.6019 4.46%
2015 22.2531 20.3183 23.8468 20.2080 21.6363 7.10%
2014 19.3386 19.0779 20.8112 17.8100 20.2015 5.30%
2013 17.8903 15.7028 20.1677 15.6665 19.1843 26.22%
2012 13.8263 12.8155 15.6363 12.3467 15.1994 20.41%
2011 11.1739 9.8979 12.7339 9.6223 12.6230 28.77%
2010 9.2040 10.1696 10.7444 7.7501 9.8027 0.31%
2009 8.2938 9.3121 10.1266 6.0735 9.7720 8.26%
2008 9.5123 10.9423 11.5011 7.3651 9.0266 -16.85%
2007 11.7909 11.9973 12.9061 10.6510 10.8564 -8.15%
2006 11.5207 10.4607 12.8761 10.0431 11.8193 15.22%
2005 11.0672 11.2890 12.5136 9.0619 10.2584 -10.62%
2004 13.9118 14.8637 16.2435 10.3671 11.4768 -22.31%
2003 13.2222 12.9377 14.9862 11.7767 14.7717 17.76%
2002 14.1860 16.1346 17.0444 10.5520 12.5437 -22.16%
2001 16.7713 18.4654 18.4654 14.3131 16.1144 -12.49%
2000 16.5605 12.6491 19.5331 11.9350 18.4134 43.06%
1999 15.2244 16.1993 19.7225 12.5229 12.8713 -21.50%
1998 13.3480 9.8523 16.5403 9.6246 16.3960 68.94%
1997 7.2878 5.2627 10.1283 5.2627 9.7053 81.93%
1996 4.6709 3.9349 5.8167 3.8401 5.3347 33.96%
1995 3.0257 2.3503 4.1878 2.3076 3.9823 66.69%
1994 1.9907 2.0418 2.4313 1.6223 2.3890 15.31%
1993 1.9032 2.1165 2.2141 1.5897 2.0718 -2.27%
1992 2.1712 2.4084 2.4586 1.9164 2.1200 -11.97%
1991 1.6853 1.1232 2.4586 1.0463 2.4084 112.74%
1990 0.9442 0.9598 1.1426 0.7646 1.1321 20.50%
1989 0.8365 0.7535 1.0105 0.7132 0.9395 24.14%
1988 0.6891 0.6107 0.7681 0.6107 0.7568 29.21%
1987 0.8181 0.7721 0.9527 0.5229 0.5857 -22.89%
1986 0.7504 0.6226 0.9060 0.5853 0.7596 20.48%
1985 0.5757 0.5027 0.6943 0.4747 0.6305 19.84%
1984 0.4443 0.4499 0.5261 0.3736 0.5261 18.17%
1983 0.4799 0.4218 0.5573 0.4218 0.4452 3.80%
1982 0.3763 0.3269 0.4966 0.3129 0.4289 29.34%
1981 0.3064 0.3316 0.3409 0.2537 0.3316 0.00%
1980 0.2586 0.2335 0.3316 0.2032 0.3316 35.29%
1979 0.2077 0.2062 0.2537 0.1821 0.2451 18.87%
1978 0.1978 0.1704 0.2390 0.1588 0.2062 21.01%
1977 0.1664 0.1790 0.1790 0.1463 0.1704 -6.43%
1976 0.1758 0.1767 0.1946 0.1588 0.1821 4.90%
1975 0.1860 0.2000 0.2273 0.1494 0.1736 -14.57%
1974 0.2065 0.2693 0.2747 0.1346 0.2032 -24.55%
1973 0.2732 0.2716 0.3261 0.2421 0.2693 0.86%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $171.018B $58.496B
Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare Disease, Hospital, Vaccines and Internal Medicine. Pfizer spinned-off its Upjohn unit, its off-patent branded and generic established medicines business, and combined it with generic drugmaker Mylan to create a new generic pharmaceutical company called Viatris. The Consumer Healthcare (CHC) segment, an over-the-counter (OTC) medicines business, was merged with Glaxo's unit to form a new joint venture.?The Consumer Healthcare joint venture with Glaxo and the merger of Upjohn unit with Mylan has made Pfizer a smaller company with a diversified portfolio of innovative drugs and vaccines.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $780.463B 112.80
Novo Nordisk (NVO) Denmark $573.776B 44.09
Johnson & Johnson (JNJ) United States $384.202B 15.23
AbbVie (ABBV) United States $321.688B 17.02
Merck (MRK) United States $318.754B 57.99
AstraZeneca (AZN) United Kingdom $243.454B 21.69
Novartis AG (NVS) Switzerland $224.697B 15.61
Sanofi (SNY) $134.488B 12.73
Innoviva (INVA) United States $1.136B 7.98